Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.
about
MTHFR C677T Polymorphism is Associated with Tumor Response to Preoperative Chemoradiotherapy: A Result Based on Previous ReportsMTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer.Delimiting Allelic Imbalance of TYMS by Allele-Specific AnalysisMolecular diagnostics for pharmacogenomic testing of fluoropyrimidine based-therapy: costs, methods and applications.The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens.Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review.Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis.Association of thymidylate synthase polymorphisms with the tumor response to preoperative chemoradiotherapy in rectal cancer: a systematic review and meta-analysis.Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samples.Progress in rectal cancer treatment.A meta-analysis identifies ERCC1 gene polymorphism as a predictor of better patient response to treatment with radiochemotherapy.Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer
P2860
Q26784493-1C51B2C8-887F-4129-940B-0CC9FDCF16A0Q34692175-CE58E832-2FA5-46B3-8F08-64130A600B84Q35623320-B76E35AA-825A-4E7F-BA22-AB53C17FEACFQ35858190-BA9097A1-EDFA-4805-B1E7-047D3A81850AQ37866805-A95EACDD-033B-4193-B3CC-5E51F77F6BB1Q38005612-0AED7911-B4FF-4158-A4FF-C41A43B72A4EQ38367771-5D9B76F3-42C1-4FF3-929A-ABCE393611E9Q38539917-4BAA1B18-443C-430D-B655-889D5A5F62CBQ38784074-7253F5AE-3B98-42EE-A35A-3BC847938B01Q39307013-38443EB4-DC77-4B10-B61B-7742D78C2332Q39554319-034B5F9F-DF27-492B-9209-4F09CE180B79Q40705223-4F4DD2B2-CED1-402C-BC30-8DD44CF079CCQ56777795-4EA6964B-3BFE-4FBA-A406-3E554706BD9F
P2860
Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Pharmacogenetic analysis in ne ...... their relation with response.
@en
Pharmacogenetic analysis in ne ...... their relation with response.
@nl
type
label
Pharmacogenetic analysis in ne ...... their relation with response.
@en
Pharmacogenetic analysis in ne ...... their relation with response.
@nl
prefLabel
Pharmacogenetic analysis in ne ...... their relation with response.
@en
Pharmacogenetic analysis in ne ...... their relation with response.
@nl
P2093
P2860
P50
P356
P1433
P1476
Pharmacogenetic analysis in ne ...... d their relation with response
@en
P2093
Catuxa Celeiro-Muñoz
Emilia Balboa
Rafael Lopez
P2860
P304
P356
10.2217/PGS.10.51
P577
2010-06-01T00:00:00Z